Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness.
Journal Information
Full Title: Transl Cancer Res
Abbreviation: Transl Cancer Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-1885/coif). S.R.J. reports grant from Varian Medical Systems to study the oropharyngeal microbiome in HNC patients, and consulting fees from Enlace health to consult on radiation oncology payment models for insurance companies. The other authors have no conflicts of interest to declare."
"Funding: This work was supported by the National Natural Science Foundation of China ( No. 81974571 ) and Guangdong Basic and Applied Basic Research Foundation ( No. 2022A1515110859 )."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025